| dc.contributor.advisor | 吳文傑 | zh_TW |
| dc.contributor.advisor | Wu, Jack | en_US |
| dc.contributor.author (Authors) | 邱翰昇 | zh_TW |
| dc.contributor.author (Authors) | Chiu, Han-Sheng | en_US |
| dc.creator (作者) | 邱翰昇 | zh_TW |
| dc.creator (作者) | Chiu, Han-Sheng | en_US |
| dc.date (日期) | 2018 | en_US |
| dc.date.accessioned | 1-Jun-2018 17:39:13 (UTC+8) | - |
| dc.date.available | 1-Jun-2018 17:39:13 (UTC+8) | - |
| dc.date.issued (上傳時間) | 1-Jun-2018 17:39:13 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0102933009 | en_US |
| dc.identifier.uri (URI) | http://nccur.lib.nccu.edu.tw/handle/140.119/117447 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 國際經營管理英語碩士學位學程(IMBA) | zh_TW |
| dc.description (描述) | 102933009 | zh_TW |
| dc.description.abstract (摘要) | The purpose of this thesis is to check the readiness of a medium size family company, H Biotechnology Company, for initial public offering (IPO). In recent, like most of small and medium size companies, H Company faces a bottleneck to grow due to difficulties of recruiting suitable elites as well as raising money from financing channels. Moreover, it is also not an easy task for an unknown medium size company to initiate transactions with big or foreign companies that did not have any cooperation experience before; however, it is the road a medium size company must take in order to grow well. Therefore, IPO is an option that H Company must take into consideration. Starting from preparation to IPO, the company will scan itself from bottom up thoroughly and make positive changes accordingly throughout the process. Once IPO successfully, there will be more chances and resources for the company to recruit talents and grow. Through preliminary scan in this thesis, hope to point out some parts that H Company has to improve in order to IPO in the near future. | en_US |
| dc.description.tableofcontents | 1. Executive Summary 11.1 Purpose 11.2 Small and Medium Enterprise in Taiwan 11.3 Capital Market in Taiwan 21.4 The Company 31.5 The Industry 31.6 The Competitor 41.7 The Customer 51.8 The Management 51.9 The Financials 61.10 The IPO Evaluation 61.11 Brief Summary 72. Small and Medium Enterprise in Taiwan 82.1 Role and Trend 82.2 Length of Existence 132.3 Distribution by Industry 152.4 Funding 162.5 Challenges 173. Capital Market in Taiwan 193.1 Capital Markets Overview 193.2 Stepwise review to each level markets 204. The Company 254.1 Vision and Mission 254.2 History 254.3 Location 264.4 Organization Structure 264.5 Products and Business Model 284.6 Shareholders 294.7 Bottleneck and Why IPO 295. The Industry 315.1 Evolution of Biotechnology Industry in Taiwan 315.2 Statistical Data of the Industry 325.3 H Company in the Industry 336. The Competitor 346.1 Medical Products 346.2 Cosmetics Products 346.3 Conclusions 387. The Customer 407.1 Target Customers and Needs 407.2 Fulfilments of Customer Needs 408. The Management 429. The Financials 459.1 Financial Positions 459.2 Income Performance 469.3 Pro-forma Financial Performance 499.4 Conclusion 5910. The IPO Evaluation 6210.1 IPO Evaluation 6210.2 Plan 6510.3 Conclusions 68Reference 69Appendix 70 | zh_TW |
| dc.format.extent | 1291616 bytes | - |
| dc.format.mimetype | application/pdf | - |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0102933009 | en_US |
| dc.subject (關鍵詞) | 首次公開募股 | zh_TW |
| dc.subject (關鍵詞) | 中小型企業 | zh_TW |
| dc.subject (關鍵詞) | IPO | en_US |
| dc.subject (關鍵詞) | SME | en_US |
| dc.title (題名) | 中小企業股票初次公開發行之挑戰 : 以H生技公司為例 | zh_TW |
| dc.title (題名) | The challenge of small and medium enterprise for initial public offering: a case of h biotechnology company | en_US |
| dc.type (資料類型) | thesis | en_US |
| dc.relation.reference (參考文獻) | 1. Regulations from Taiwan Stock Exchange (http://www.twse.com.tw)2. Regulations from Taipei Exchange (http://www.tpex.org.tw)3. 2017生技產業白皮書 by經濟部生技醫藥產業發展推動小組(http://www.biopharm.org.tw)4. 2017 中小企業白皮書 by 經濟部中小企業處(http://www.moeasmea.gov.tw) | zh_TW |
